Adjuvant chemotherapy may improve long-term outcomes in stage IB non-small cell lung cancer patients with previous malignancies: A propensity score-matched analysis

BACKGROUND: Routine administration of adjuvant chemotherapy for stage IB non-small cell lung cancer (NSCLC) remains controversial. To our knowledge, no available studies have assessed the outcomes of chemotherapy in patients with stage IB NSCLC who had prior malignancies. METHODS: Patients with path...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Ke, Zhao, Yaqin, Liang, Linchuan, Cao, Jie, Lin, Huahang, Peng, Zhiyu, Mei, Jiandong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472252/
https://www.ncbi.nlm.nih.gov/pubmed/36119504
http://dx.doi.org/10.3389/fonc.2022.938195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472252/
https://www.ncbi.nlm.nih.gov/pubmed/36119504
http://dx.doi.org/10.3389/fonc.2022.938195

Ejemplares similares